Moreover, further studies focused on possible biomarkers for disease progression and described how serine proteases C1r and C1s are significantly overexpressed in advanced cSCC from RDEB patients, suggesting their potential for use not only in predicting disease progression but also as potential targets for new therapeutic approaches in metastatic cSCC [32]. Here, C1S is linked to skin squamous cell carcinoma.